Last edition
News about
Dr Reddy's Welcomes Unified GST Reform to Support Pharma Manufacturing
Reddy said he expects the reform to address these critical issues, improve medicine affordability, and enhance India’s competitiveness and innovation in the global pharmaceutical supply chain. He emphasised that a reformed GST system would not only benefit patients but also reinforce India’s role in global healthcare security.
Samsung Launches Mobile CT Technologies Portfolio in India
Samsung has unveiled its next-generation mobile CT solutions in India to transform diagnostic and interventional radiology.
AbbVie to Acquire Gilgamesh's Psychedelic Antidepressant Bretisilocin in USD 1.2 Billion Deal
AbbVie has announced a USD 1.2 billion deal to acquire Gilgamesh Pharmaceuticals’ lead candidate bretisilocin, a next-generation psychedelic compound in clinical development for treating moderate-to-severe major depressive disorder.
Novartis Expands Collaboration with BioArctic, Eyes Licensing Opportunity Worth Up to $772 Million
The partnership focuses on combining BioArctic’s BrainTransporter technology with a Novartis proprietary antibody to develop a novel drug candidate. Should Novartis proceed, it would take full responsibility for the candidate’s global development and commercialization.
Scenic Biotech Partners with Alnylam to Advance RNAi Therapeutics Using Cell-Seq Platform
This collaboration represents Scenic Biotech’s third Cell-Seq collaboration with major US biotech and pharmaceutical companies, following ongoing multi-year agreements with Genentech and Bristol Myers Squibb. <br />
Er-Kim Partners with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
Istanbul-based Er-Kim, an international pharmaceutical company specialising in the commercialisation of novel therapies, has entered into a distribution agreement with UK-based CNX Therapeutics to supply selected oncology products across Central and Eastern Europe (CEE) and Turkey.
Eris Lifesciences Secures ANVISA Approval for Sterile Injectable Facility in Ahmedabad
Eris Lifesciences has received Anvisa approval for one of its sterile injectable manufacturing facilities in Ahmedabad, enabling entry into the Brazilian market.
Malaysia, Singapore Partner to Launch Medical Device Regulatory Reliance Pilot
The Medical Device Authority (MDA) of Malaysia and the Health Sciences Authority (HSA) of Singapore have signed a Memorandum of Understanding (MOU) to deepen regulatory cooperation and officially launched a 6-month pilot of the Medical Device Regulatory Reliance Programme.
CDSCO Cancels Import Registration of Mediderma Products Over Excess Salicylic Acid
The Central Drugs Standard Control Organisation (CDSCO) has cancelled the import registration of certain skincare products from US-based Mediderma after finding salicylic acid levels far above the permissible limit.
Cambrex Expands Snapdragon Chemistry Facility to Boost Peptide Therapy Manufacturing
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the expansion of its Snapdragon Chemistry API facility in Waltham, Massachusetts, strengthening its capabilities in peptide drug development and manufacturing.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy